The UK says it will invest $127 million in a manufacturing facility to scale up production of COVID-19 vaccines and gene therapies. Read More

Dynavax has partnered with Taiwan-based Medigen Vaccine Biologics to develop a COVID-19 vaccine candidate. The partners will evaluate Medigen’s recombinant form of the SARS-CoV2 spike protein combined with Dynavax’s CpG1018 adjuvant. Read More

Since February, the FDA has approved 361 generic drug applications and okayed nearly 300 manufacturing changes to help speed drugs to market for COVID-19 patients, FDA Commissioner Stephen Hahn said this week. He was touting the agency’s prompt response to the pandemic even though the agency’s numbers don’t back up that claim. Read More

Pfizer confirmed that it plans to charge $19.50 per dose of its COVID-19 vaccine in the U.S., with a total cost of about $40 for a two-dose regimen. Read More

India-based Glenmark Pharmaceuticals says its antiviral favipiravir has shown promise as a COVID-19 treatment in mild to moderate patients. Read More

HHS and the Department of Defense have signed their largest deal to date under Operation Warp Speed — a $1.95 billion contract with Pfizer and BioNTech for large-scale production and nationwide delivery of 100 million doses of their COVID-19 vaccine. Read More

The drug was generally well tolerated, with no serious adverse events or deaths, the company said. Read More

The Department of Justice announced yesterday that two Chinese hackers have been indicted on charges of trying to hack COVID-19 vaccine research in the U.S. Read More